Safety and pharmacokinetics of the orally available antiprionic compound PRI‐002: A single and multiple ascending dose phase I study von Kutzsche, Janine, Jürgens, Dagmar, Willuweit, Antje, Adermann, Knut, Fuchs, Carola, Simons, Stefanie, Windisch, Manfred, Hümpel, Michael, Rossberg, Wolfgang, Wolzt, Michael, Willbold, Dieter

Volltext

Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer's Disease von Kutzsche, Janine, Schemmert, Sarah, Tusche, Markus, Neddens, Jörg, Rabl, Roland, Jürgens, Dagmar, Brener, Oleksandr, Willuweit, Antje, Hutter-Paier, Birgit, Willbold, Dieter

Volltext

Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease von Kutzsche, Janine, Schemmert, Sarah, Bujnicki, Tuyen, Zafiu, Christian, Halbgebauer, Steffen, Kraemer-Schulien, Victoria, Pils, Marlene, Blömeke, Lara, Post, Julia, Kulawik, Andreas, Jürgens, Dagmar, Rossberg, Wolfgang M., Hümpel, Michael, Bannach, Oliver, Otto, Markus, Araujo, Joseph A., Willuweit, Antje, Willbold, Dieter

Volltext

Clinical phase I data of the first orally available anti‐aβ‐prionic drug PRI‐002 that reverses behavioral and cognitive deficits, and decelerates neurodegeneration in AD animal mod... von Willbold, Dieter, Kutzsche, Janine, Willuweit, Antje, Windisch, Manfred, Jürgens, Dagmar

Volltext

Clinical phase I data of the first orally available anti‐aβ‐prionic drug PRI‐002 that reverses behavioral and cognitive deficits, and decelerates neurodegeneration in AD animal mod... von Willbold, Dieter, Kutzsche, Janine, Willuweit, Antje, Windisch, Manfred, Jürgens, Dagmar

Volltext

The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology von van Groen, Thomas, Schemmert, Sarah, Brener, Oleksandr, Gremer, Lothar, Ziehm, Tamar, Tusche, Markus, Nagel-Steger, Luitgard, Kadish, Inga, Schartmann, Elena, Elfgen, Anne, Jürgens, Dagmar, Willuweit, Antje, Kutzsche, Janine, Willbold, Dieter

Volltext

An orally available Cav2.2 calcium channel inhibitor for the treatment of neuropathic pain von Kutzsche, Janine, Guzman, Gustavo A., Willuweit, Antje, Kletke, Olaf, Wollert, Esther, Gering, Ian, Jürgens, Dagmar, Breitkreutz, Jörg, Stark, Holger, Beck‐Sickinger, Annette G., Klöcker, Nikolaj, Hidalgo, Patricia, Willbold, Dieter

Volltext

An orally available Ca v 2.2 calcium channel inhibitor for the treatment of neuropathic pain von Kutzsche, Janine, Guzman, Gustavo A., Willuweit, Antje, Kletke, Olaf, Wollert, Esther, Gering, Ian, Jürgens, Dagmar, Breitkreutz, Jörg, Stark, Holger, Beck‐Sickinger, Annette G., Klöcker, Nikolaj, Hidalgo, Patricia, Willbold, Dieter

Volltext

P4‐671: DO WE NEED ANTI‐PRIONIC COMPOUNDS TO TREAT ALZHEIMER'S DISEASE? von Willbold, Dieter, Kutzsche, Janine, Schemmert, Sarah, Willuweit, Antje, Jürgens, Dagmar

Volltext

DO WE NEED ANTI-PRIONIC COMPOUNDS TO TREAT ALZHEIMER’S DISEASE? von Willbold, Dieter, Kutzsche, Janine, Schemmert, Sarah, Willuweit, Antje, Jürgens, Dagmar

Volltext

P4‐672: EXPLORING A POTENTIALLY DIFFERENT OR ADDITIONAL MOA FOR THE CLINICAL STAGE COMPOUND PRI‐002 von Willbold, Dieter, Kutzsche, Janine, Schemmert, Sarah, Willuweit, Antje, Jürgens, Dagmar

Volltext

EXPLORING A POTENTIALLY DIFFERENT OR ADDITIONAL MOA FOR THE CLINICAL STAGE COMPOUND PRI-002 von Willbold, Dieter, Kutzsche, Janine, Schemmert, Sarah, Willuweit, Antje, Jürgens, Dagmar

Volltext

QIAD assay for quantitating a compound’s efficacy in elimination of toxic Aβ oligomers von Brener, Oleksandr, Dunkelmann, Tina, Gremer, Lothar, van Groen, Thomas, Mirecka, Ewa A., Kadish, Inga, Willuweit, Antje, Kutzsche, Janine, Jürgens, Dagmar, Rudolph, Stephan, Tusche, Markus, Bongen, Patrick, Pietruszka, Jörg, Oesterhelt, Filipp, Langen, Karl-Josef, Demuth, Hans-Ulrich, Janssen, Arnold, Hoyer, Wolfgang, Funke, Susanne A., Nagel-Steger, Luitgard, Willbold, Dieter

Volltext

Aβ oligomer eliminating compounds interfere successfully with pEAβ(3–42) induced motor neurodegenerative phenotype in transgenic mice von Dunkelmann, Tina, Teichmann, Kerstin, Ziehm, Tamar, Schemmert, Sarah, Frenzel, Daniel, Tusche, Markus, Dammers, Christina, Jürgens, Dagmar, Langen, Karl-Josef, Demuth, Hans-Ulrich, Shah, Nadim Jon, Kutzsche, Janine, Willuweit, Antje, Willbold, Dieter

Volltext

An orally available N-type calcium channel inhibitor for the treatment of neuropathic pain von Kutzsche, Janine, Guzman, Gustavo A, Willuweit, Antje, Kletke, Olaf, Wollert, Esther, Gering, Ian, Jürgens, Dagmar, Breitkreutz, Jörg, Stark, Holger, Beck-Sickinge, Annette G, Klöcker, Nikolaj, Hidalgo, Patricia, Willbold, Dieter

Volltext

QIAD assay for quantitating a compound's efficacy in elimination of toxic A[beta] oligomers von Brener, Oleksandr, Dunkelmann, Tina, Gremer, Lothar, Van Groen, Thomas, Mirecka, Ewa A, Kadish, Inga, Willuweit, Antje, Kutzsche, Janine, Jürgens, Dagmar, Rudolph, Stephan, Tusche, Markus, Bongen, Patrick, Pietruszka, Jörg, Oesterhelt, Filipp, Langen, Karl-josef, Demuth, Hans-ulrich, Janssen, Arnold, Hoyer, Wolfgang, Funke, Susanne A, Nagel-steger, Luitgard, Willbold, Dieter

Volltext

D-ENANTIOMERIC PEPTIDES FOR THE THERAPY OF CHRONIC AND NEUROPATHIC PAIN von JÜRGENS, Dagmar, WILLBOLD, Dieter, KUTZSCHE, Janine, JIMENEZ, Patricia Hidalgo, CASTRO, Gustavo Adolfo Guzman

Volltext bestellen

PRODUCTION AND CHARACTERIZATION OF ESCHERICHIA COLI ENTEROHEMOLYSIN AND ITS EFFECTS ON THE STRUCTURE OF ERYTHROCYTE MEMBRANES von Jürgens, Dagmar, Özel, Muhsin, Takaisi-Kikuni, Ntondo B.

Volltext

Identification of Legionella species by lipopolysaccharide antigen pattern von JÜRGENS, D, FEHRENBACH, F.-J

Volltext

Unspecific binding of group B streptococcal cocytolysin (CAMP factor) to immunoglobulins and its possible role in pathogenicity von JÜRGENS, D, STERZIK, B, FEHRENBACH, F. J

Volltext